ArticleAnnals of surgical treatment and research2026
Laparoscopic
Article in Annals of surgical treatment and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study was performed to compare perioperative and oncologic outcomes between laparoscopic and open liver resection following transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC). TARE is increasingly used as a bridge therapy for HCC when immediate resection is not feasible. However, the safety and efficacy of subsequent laparoscopic liver resection compared to open surgery remain unclear. Methods: We retrospectively analyzed 65 patients who underwent liver resection after TARE for HCC between 2012 and 2023 at a single high-volume center. Propensity score matching based on age, sex, tumor size, and tumor markers (AFP, PIVKA-II) yielded 18 matched pairs for laparoscopic and open surgery. Results: The laparoscopic group demonstrated shorter time from TARE to operation (99.7 days Conclusion: Laparoscopic liver resection following TARE appears to be a safe and effective approach for selected HCC patients, offering comparable oncologic outcomes to open surgery while achieving shorter hospitalization. These findings support the consideration of minimally invasive approaches in appropriate candidates after TARE at experienced centers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.